Equillium (EQ) Liabilities and Shareholders Equity (2017 - 2026)

Equillium's (EQ) quarterly Liabilities and Shareholders Equity came in at $63.1 million in Q1 2026, up 277.09% year-on-year from $16.7 million in Q1 2025, and up 97.83% on a QoQ basis from $31.9 million in Q4 2025.

Equillium (EQ) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

Equillium (EQ) has 10 years of Liabilities and Shareholders Equity data on file, last reported at $63.1 million in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 277.09% year-over-year to $63.1 million in Q1 2026; TTM through Mar 2026 was $141.9 million, a 18.57% increase from a year earlier, with the FY2025 full-year figure at $31.9 million, up 24.54% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $63.1 million, up from $31.9 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for EQ reached as high as $71.8 million in Q1 2023 and fell as low as $12.4 million in Q2 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $38.8 million across 5 years, with a median of $34.5 million in 2025.
  • Across the five-year window, Liabilities and Shareholders Equity tumbled 78.43% in 2022 and jumped 277.09% in 2026, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $23.0 million in 2022, then soared by 119.23% to $50.5 million in 2023, then tumbled by 49.33% to $25.6 million in 2024, then rose by 24.54% to $31.9 million in 2025, then jumped by 97.83% to $63.1 million in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $63.1 million in Q1 2026, $31.9 million in Q4 2025, and $34.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 311.58 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 78.88 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 33.89 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 8.55 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 26.48 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 40.87 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 811.27 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 2.25 Bn
10 Equillium 242.14 Mn 242.14 Mn - 63.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 63.08 Mn
Dec 31, 2025 31.89 Mn
Sep 30, 2025 34.51 Mn
Jun 30, 2025 12.40 Mn
Mar 31, 2025 16.73 Mn
Dec 31, 2024 25.60 Mn
Sep 30, 2024 34.46 Mn
Jun 30, 2024 42.86 Mn
Mar 31, 2024 43.60 Mn
Dec 31, 2023 50.53 Mn
Sep 30, 2023 55.23 Mn
Jun 30, 2023 58.76 Mn
Mar 31, 2023 71.79 Mn
Dec 31, 2022 23.05 Mn
Sep 30, 2022 48.63 Mn
Jun 30, 2022 23.05 Mn
Mar 31, 2022 23.05 Mn
Dec 31, 2021 85.41 Mn
Sep 30, 2021 92.47 Mn
Jun 30, 2021 99.84 Mn